Assessment of infant development during an 18-month follow-up after treatment of infections in pregnant women with cefuroxime axetil

Drug Safety

Volumn 22, Issue 1, 2000, Pages 83-88

  Manka, Wiktor ^a   Solowiow, Rafal ^a   Okrzeja, Dariusz ^b  

^a Independent Public Health Care Unit   (Poland)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFUROXIME AXETIL;

ADULT; ANTIBIOTIC RESISTANCE; APGAR SCORE; ARTICLE; CYSTITIS; DRUG EFFICACY; DRUG SAFETY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; IMMINENT ABORTION; INFECTION; MAJOR CLINICAL STUDY; MENTAL DEVELOPMENT; PHYSICAL DEVELOPMENT; POSTNATAL DEVELOPMENT; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROLONGED PREGNANCY; PYELONEPHRITIS; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; SECOND TRIMESTER PREGNANCY; SIDE EFFECT; THIRD TRIMESTER PREGNANCY; TREATMENT OUTCOME;

EID: 0033957601     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200022010-00007     Document Type: Article

References (19)

1. 1. Gamsu HR. Bacterial, fungal and protozoal infections in pregnancy and the newborn. In: Weatherall DJ, Ledingham JGG, Warrell DA, editors. Oxford textbook of medicine. CD version
2. 2. Wise R. Prescribing in pregnancy: antibiotics. BMJ 1987; 294: 42-6
3. 3. Physicians Desk Reference 53rd edition. Montvale (NJ): Medical Economics Company, 1999: 3019
4. 4. Physicians Desk Reference 53rd edition. Montvale (NJ): Medical Economics Company, 1999: 920
5. 5. Dyer IE, Sankary TM, Dawson JA. Antibiotic resistance in bacterial urinary tract infections, 1991 to 1997. West J Med 1998; 169 (5): 265-8
6. 6. Bousefield P, Browning AK, Mullinger BM, at al. Cefuroxime: potential use in pregnant women at term. Br J Obstet Gynaecol 1981; 88: 146-9
7. 7. Craft I, Mullinger BM, Kennedy MRK. Placental transfer of cefuroxime. Br J Obstet Gynaecol 1981; 88: 141-5
8. 8. Physicians Desk Reference 53rd edition. Montvale (NJ): Medical Economics Company, 1999: 1098
9. 9. Perry CM, Brogden RN. Cefuroxime axetil: a review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1996; 52 (1): 125-58
10. 10. Hamilton P. Care of the newborn in the delivery room. BMJ 1999; 318: 1403-6
11. 11. Rubin PC. Prescribing in pregnancy. In: Weatherall DJ, Ledingham JGG, Warrell DA, editors. Oxford textbook of medicine. CD version
12. 12. Craft I. Placental transfer of cephalosporins. Res Clin Forums 1984; 6 (2): 45-52
13. 13. Chow AW, Jewesson PJ. Pharmacokinetics and safety of antimicrobial agents during pregnancy. Rev Infect Dis 1985; 7 (3): 287-313
14. 14. Cefuroxime. In: Briggs GG, Freeman RK, Yaffe SJ, editors. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 5th edition, Baltimore (MD): Williams & Wilkins, 1988: 169/c
15. 15. De Louvois J. Cefuroxime in treatment of neonates. Arch Dis Child 1982; 57: 59-62
16. 16. Wilkinson PJ, Belohradsky BH, Marget W. A clinical study of cefuroxime in neonates. Proc R Soc Med 1977; 70 Suppl. 9: 183-7
17. 17. Salvioli GP, Camerlo F. Evolution of antibiotic treatment with beta-lactams: the methoximines. Proceedings of an International Conference; 1980 Apr 25-26; Rome. Milan: Masson Italia Editori, 1982: 131-4
18. 18. Jafusco F, Ansanelli V, Di Lena C. The therapeutic use of cefuroxime in neonates. Proceedings of an International Conference; 1980 Apr 25-26; Rome. Milan: Masson Italia Editori, 1982: 151-9
19. 19. Sutton A, Fleet H, Ng SH, et al. The role of cefuroxime and gentamicin in neonates: a comparative study. In: Cefuroxime update. R Soc Med Int Congr Symp 19; 38: 153-61